Stephen B. Maebius

Stephen B. Maebius

Foley & Lardner LLP

Contact  |  View Bio  |  RSS

Latest Posts › Patents

Share:

Evolving Healthcare Trends & Patents: Charting a Safe Course for Personalized Medicine

Rapid changes resulting from personalized medicine, including the ability to use individual patient biomarker data to generate a tailored treatment, are transforming healthcare. New business structures are evolving in the...more

8/7/2014 - AMP v Myriad Healthcare Healthcare Reform Mayo v. Prometheus Patent Infringement Patent Litigation Patents SCOTUS

U.S. PTAB Issues First Final Decision in an Inter Partes Review

On November 13, 2013, the U.S. Patent Trial and Appeal Board (PTAB) issued its first final decision in an inter partes review (IPR) proceeding brought by Garmin under the new administrative procedures established by the...more

11/15/2013 - America Invents Act Inter Partes Review Proceedings Patent Reform Patent Trial and Appeal Board Patents

NanoBusiness Panel on Patents Featuring View From the US Patent Office

At a recent nanotech conference hosted by the NanoBusiness Commercialization Association, we received an update on nanotech patent trends from Jerry Lorengo, a Group Director with the US Patent Office. Jerry provided a great...more

11/13/2013 - Nanotechnology Patents Technology USPTO

Supreme Court Decides Myriad Case: Synthetic DNA Held Patentable & Implications for Nanotech

Today the Supreme Court rendered its decision in the landmark Myriad case, holding that naturally occurring DNA segments are not patentable, but synthetic DNA segments are patent eligible based on the patent eligibility...more

6/17/2013 - AMP v Myriad DNA Myriad Nanotechnology Patent-Eligible Subject Matter Patents SCOTUS

U.S. Patent "Micro-Entity" Rules & Other Cost Savings Strategies: Do You qualify for 75% Off Your U.S. Patent Filing Costs?

The short answer is that a company or individual who already is qualified as a small entity (which entitles you to 50% off U.S. patent filing costs) may also qualify under the final rules issued by the Patent Office for...more

6/14/2013 - Filing Fees Micro Entity Status Patent Applications Patents USPTO

Will the Supreme Court Limit Nanotech Patents?

In a case styled The Association for Molecular Pathology v. Myriad Genetics, the Supreme Court is confronting the question of whether or not human genes are patent eligible under 35 U.S.C. 101. A decision is expected in the...more

6/4/2013 - AMP v Myriad Biotechnology Gene Patenting Human Genes Infringement Myriad Nanotechnology Patents SCOTUS

Nanomedicine Hitting Its Stride? Beware of Patent Risks

Though the first nanoparticulate drug formulation was approved by the U.S. FDA way back in 1995, a recent flurry of deals and product approvals have shown increasingly high valuations for nanomedicine companies....more

6/4/2013 - FDA Nanomedicine Patents Pharmaceutical Safe Harbors

EU Moves Closer to a "Unitary" Patent Regime for Obtaining and Litigating Patents in Europe

On December 11, 2012, the European Parliament approved a set of three proposals to create (1) a “unitary” patent valid across 25 EU member states, (2) a simplified language regime for EU patents, and (3) a unified patent...more

12/13/2012 - EU Patents Unified Patent Court Unitary Patent

8 Results
|
View per page
Page: of 1